Skip to content

Company

Genentech

Description

Headquarters
US

Structure of Genentech

Genentech

Company

7 connections
OwnershipInvestment and holdings
UpstreamSupply and dependency2 of 3
DownstreamCustomers
ConstraintsRegulation and exposure
Relationship began2026
GenentechCompany · 7 connections
Layer 1

UpstreamSupply and dependency2

DownstreamCustomers1

OwnershipInvestment and holdings2

ConstraintsRegulation and exposure2

Relations

Arrows show the direction of the relationship. Filter to focus on a business area.

Showing 1 to 8 of 8

Claims

Read the assertion alongside its sources. Expand a row to inspect the evidence.

FactEvidence 1
ownsRoche

Genentech in the United States is a fully owned subsidiary in the Roche Group.

PR Newswire news releases · 2026-10-07 13:00

View evidence
  • CompanyPR Newswire news releases2026-10-07 13:00
    Genentech in the United States is a fully owned subsidiary in the Roche Group.
    View source
FactEvidence 1
commercial operations start year2,031 year

No public evidence summary is available.

Construction Dive · 2026-10-02 21:18

View evidence
FactEvidence 1
investment amount750,000,000 USD

No public evidence summary is available.

Construction Dive · 2026-10-02 21:18

View evidence
FactEvidence 2

No public evidence summary is available.

Construction Dive · 2026-10-02 21:18

View evidence
FactEvidence 1
facility size increase211,000 square feet

No public evidence summary is available.

Construction Dive · 2026-10-05 21:47

View evidence
FactEvidence 2

No public evidence summary is available.

Construction Dive · Manufacturing Dive · 2026-10-05 21:47

View evidence

Showing 1 to 6 of 16

Market and valuation

Valuation data is available on Pro and Research.

Included in Pro

Not available: Company signals · Financials · Filings · Guidance